Blog Article

FDA 21 CFR Part 11 playbook: a buyer's evaluation checklist for eQMS RFPs

A vendor-evaluation checklist — what to ask, what evidence to demand, and what answers fail Part 11 in an inspection.

Use this checklist during eQMS shortlisting. Each control area has the exact question to ask, the artifact to request, and the failure mode that should knock a vendor off the list.

FDA 21 CFR Part 11 playbook — electronic records, e-signatures, audit trail controls

How to use this checklist

This is a Part 11 RFP scorecard, not a regulatory primer. Each section has the question to put into your RFP, the artifact to demand from the vendor, and the failure mode that should disqualify a response. Score each control area pass/fail against the artifact, not the marketing answer.

Buyer questions every vendor must answer

Most teams are not looking for abstract compliance claims. They want to know whether the system produces controlled records, maintains a readable history, limits access appropriately, and ties sign-off events to specific actions.

  • Can the system show who approved what and when? (Artifact: signed audit trail export)
  • Can we retrieve record history quickly during inspection? (Artifact: timed retrieval demo)
  • How are signatures and user roles handled in daily workflows? (Artifact: e-signature SOP + screenshot)
  • Does the vendor ship a Part 11 traceability matrix? (Artifact: TM mapping §11.10/§11.50/§11.300)
  • What happens to the audit trail when a tenant is offboarded? (Artifact: retention + export procedure)

How Complere supports Part 11 compliance

Complere connects Part 11 requirements to daily quality operations: role-based access controls limit who can create, review, and approve records. Workflow sign-off points capture electronic signatures with re-authentication and intent. Time-stamped audit trails record every action, change, and access event across documents, CAPA, audits, training, and change control.

Key control areas

Electronic records, electronic signatures, audit trails, access controls, and system validation — Complere addresses all five core Part 11 control areas in a single governed platform.

Frequently asked questions

Questions readers commonly ask about FDA 21 CFR Part 11 playbook: a buyer's evaluation checklist for eQMS RFPs.

Can software be '21 CFR Part 11 compliant' on its own?

No software is compliant by itself. Part 11 compliance is a property of how a regulated organization configures, validates, and uses a system within its quality processes. A vendor can provide Part 11-capable features — controlled electronic records, electronic signatures, audit trail, access control — but the firm is responsible for validation and procedural controls. Evaluate vendors on the artifacts they produce, not on a 'compliant' label.

What should an RFP ask a vendor about 21 CFR Part 11?

For each control area, ask the specific question, demand the supporting artifact, and define the failure mode that disqualifies the answer. Concretely: request an audit-trail sample, a signature-manifestation record, a configuration export, and a description of how access roles are enforced. Score pass/fail against the artifact the vendor produces, not the marketing claim.

Which controls matter most when evaluating Part 11 software?

The core controls a regulated buyer should verify are electronic records (controlled, retrievable, with version history), electronic signatures (with the manifestation and record-binding Part 11 requires), audit trail (attributable, time-stamped, reviewable), and role-based access control. These are the areas where inspection evidence is most often tested.

About the author

Co-founder, Validation & Engineering, DevOps Lead

Compliance and quality-systems specialist writing for regulated SaaS buyers in pharma, medical device, biotech, and CDMO. All posts reviewed against current FDA, MHRA, EMA, ICH, and PIC/S guidance before publication.

Continue Exploring

Explore related topics, modules, and compliance resources for a deeper understanding of your quality system.

Electronic records workflow
Related

Electronic Records & Signatures

How §11.10 and §11.50 controls sit inside everyday approvals and audit trails.

Explore
Data integrity
Related

Data Integrity & Audit Trails

ALCOA+, audit trails, and controlled access applied from record creation through inspection.

Explore
Audit Readiness
Related

Audit Readiness

Documents, CAPA, training, and follow-up kept connected and retrievable for every inspection.

Explore

Related from the blog

More from the Complere editorial team on quality, validation, and inspection readiness.

Investigation & Risk

OOS Investigation — What FDA Still Expects in 2026

Barr still rules retesting. FDA's OOS guidance got a Level 2 revision in 2022, not a rewrite. Phase I/II files, averaging, and CAPA linkage under inspection.

Read the article
eQMS Architecture & Selection

Choosing a GxP Cloud Region: What Data Residency Actually Locks In

"Which regions do you support?" is the wrong question. Region is chosen once, at provisioning — locking in latency, service availability and DR posture.

Read the article
Regulatory Current Events

FDA Is Rewriting How You Respond to a 483. Are Your CAPAs Ready?

QMSR became effective February 2, 2026 and FDA Compliance Program 7382.850 replaced QSIT. What changed in 483 citations — and what CAPA must produce.

Read the article

See Part 11 controls in action during a focused demo

Our demo covers the exact electronic record, signature, audit trail, and access controls relevant to your team's Part 11 evaluation.